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5SUMMARY
Oxidative stress has been increasingly implicated in the pathogenesis of lung
diseases. Antioxidant mechanisms and their regulation are poorly characterized in
the human lung, but they may be important in the development and progression of
pulmonary diseases. The present study was designed to investigate the regulation
of the most important antioxidant enzymes (AOEs), superoxide dismutases
(MnSOD, CuZnSOD), catalase, and glutathione peroxidase (GPx), in human lung
cells by exposing them to agents and states (cytokines, asbestos fibers, oxidants,
and hyperoxia), which may play an important role in the pathogenesis of lung
diseases.
Enzyme regulation was investigated in cultured human bronchial
epithelial cells (BEAS-2B), pleural mesothelial cells (MET-5A), alveolar
macrophages, monocytes, and neutrophils. Enzyme expression was assessed at
the level of mRNA, protein, and/or activity. Cell injury was measured by lactate
dehydrogenase (LDH) release and/or depletion of high-energy nucleotides.
Copper-zinc superoxide dismutase was constitutively expressed in all cell types
investigated. The specific activity of MnSOD was quite low, but similar in all cell
types. It was induced by TNF-α but not by high oxygen tension or asbestos fibers
in BEAS-2B and MET-5A cells, respectively. Induction of MnSOD by TNF-α
offered no protection against subsequent oxidant exposure. Catalase, glutathione
peroxidase and reductase were constitutively expressed in BEAS-2B cells, with
no change during exposure to any agent. The activity of catalase was highest in
neutrophils, whereas glutathione levels and enzymes of the glutathione cycle
were highest in monocytes. Catalase was the main scavenger of exogenous H2O2
in alveolar macrophages and also appeared to explain the high resistance of
neutrophils against exogenous H2O2. During the respiratory burst of alveolar
macrophages, the glutathione redox cycle was mainly responsible for the
maintenance of cellular integrity. Low levels of glutathione and related enzymes
may account for the short survival of human neutrophils.
In conclusion, MnSOD is induced by TNF-α, but cytokine-induced
MnSOD does not protect lung cells against oxidant-induced damage. The
enzymes associated with the scavenging of H2O2 are not upregulated by cytokines
or oxidants, but they play an important role in scavenging of both exogenous
H2O2 and endogenous oxidants in a cell-specific manner. Because transformed
cell lines or cell culture conditions for primary cells were used, the results should
be extrapolated with caution with respect to the situation in vivo.
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8INTRODUCTION
Oxygen-derived free radicals and other reactive oxygen species (ROS) are
produced during normal cellular metabolism. ROS are potentially harmful
because they have the ability to react with and alter all principal components of
the cell, including lipids, proteins, carbohydrates, and nucleic acids. To prevent
oxidant damage, cells have evolved antioxidant enzymes (AOEs), such as
superoxide dismutase, catalase, and glutathione peroxidase, as well as
nonenzymatic scavengers. An imbalance between oxidants and antioxidants leads
to oxidative stress, which has been proposed to play an important role in the
pathogenesis of many diseases. Although damaging, ROS also have beneficial
functions as part of the host defense against micro-organisms and as cellular
signaling agents.
Reactive oxygen species appear to play an important role in the lung
both in health and in disease. Lung cells are the first to encounter inspired
oxygen, and the oxygen concentration in the lung is relatively high compared to
levels in other organs. The generation of ROS is further increased by inhaled
toxic particles and gases. Considerable evidence suggests that ROS, produced
both intracellularly by lung parenchymal cells and extracellularly by lung
macrophages and infiltrating neutrophils, play a central role in the pathogenesis
of various lung diseases, such as adult respiratory distress syndrome (ARDS),
asthma, chronic obstructive pulmonary disease (COPD), bronchopulmonary
dysplasia (BPD), granulomatous lung diseases, and asbestos-induced diseases
(Heffner and Repine 1989, Barnes 1990, Sibille and Reynolds 1990, Kamp et al.
1992, Kinnula et al. 1995).
The lungs have efficient antioxidative defense mechanisms. The
primary defense mechanisms against oxidant stress are AOEs. Based on animal
models, various lung cell types appear to differ in their resistance against
oxidants, which may in part be explained by differences in the antioxidant
defense mechanisms of the cells. Although various studies conducted on animal-
cell models in vivo and in vitro have shown that increased activities of pulmonary
AOEs confer resistance on oxidants, and that the regulation of AOEs is complex,
little is known about the role and regulation of AOEs in the human lung.
Furthermore, the protective effect of the induction of various AOEs has remained
unclear.
This series of studies aimed to compare the expression and
regulation of various AOEs as well as their relative importance in human
bronchial epithelial cells, pleural mesothelial cells, and alveolar macrophages. In
these experiments the cells were exposed to factors relevant in the pathogenesis
of oxidant-related lung diseases, such as high oxygen tension, cytokines, and
asbestos fibers. Furthermore, the significance of AOE induction in cell protection
was investigated.
9REVIEW OF THE LITERATURE
1. Reactive oxygen species (ROS)
1.1. Chemistry of ROS
A free radical is defined as any molecule or atom which contains one or more
unpaired electrons in its outer orbit (Halliwell and Gutteridge 1989). The
presence of an unpaired electron makes the species highly reactive. The lifetime
of various radicals is only a fraction of a second, but there is considerable
difference between various radicals (Pryor 1986). These compounds can be
formed by the loss of a single electron from a non-radical, by gain of a single
electron by a non-radical, or by homolytic fission, in which a covalent bond is
broken and each fragment retains its own electron. A free radical is shown in
chemical formulas by a dot, R.. The most important radicals in biological systems
are the superoxide anion (O2-
.), hydroxyl radical (OH.), nitric oxide (NO.), and the
lipid-derived peroxyl radical (ROO.) and alkoxyl radical (RO.).
The term ”reactive oxygen species” (ROS) is often used to refer to
free radicals and other oxygen-related reactive compounds, such as singlet
oxygen (1O2), hydrogen peroxide (H2O2), and hydroperoxides (ROOH) (Halliwell
and Gutteridge 1989). All these compounds have the potential to cause free-
radical reactions (Pryor 1986). When a free radical reacts with a non-radical
molecule, the target molecule is converted to a radical, which may further react
with another molecule.
The primary formation of most of the ROS is the reduction of
molecular oxygen with the formation O2-
. (Fridovich 1983, Halliwell and
Gutteridge 1989). Although the reactivity of O2-
. is quite low, it is capable of
initiating free-radical chain reactions. Superoxide undergoes a dismutation to
form H2O2 spontaneously or enzymatically (I). The spontaneous dismutation rate
is slow, whereas the reaction catalyzed by superoxide dismutases (SOD) is 104
times as fast (Halliwell and Gutteridge 1989). Superoxide can also react with
nitric oxide (NO.) to form peroxynitrite (ONOO-) (Beckman et al. 1994).
(I) O2-
. + O2-
. + 2H+ → H2O2 + O2
Hydrogen peroxide is more stable than O2-
.. It can diffuse through the plasma
membrane, and if not scavenged locally by catalase or glutathione peroxidase,
can promote radical reactions far from its origin (Halliwell and Gutteridge 1989).
The most reactive and potentially harmful radical has been
considered to be OH. (Halliwell and Gutteridge 1989). Because the lifetime of
OH. is extremely short, it can thus be expected to react at or close to its site of
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formation. The hydroxyl radical is generated from H2O2 through the Fenton
reaction catalyzed by the transition metals iron or copper (II):
(II) Fe2+ + H2O2 → Fe3+ + OH
. + OH-
or from O2-
. and H2O2 through the Haber-Weiss reaction catalyzed by iron or
copper (III) (Halliwell and Gutteridge 1989):
                 metal
(III) O2-
. + H2O2 → O2 + OH
. + OH-
                 catalyst
1.2. Sources of ROS in the lung
Reactive oxygen species are generated in the normal metabolism of all aerobic
cells. Lung cells are the first to encounter inspired oxygen, and oxygen
concentration in the lung is higher than levels in other organs. The basic findings
on ROS generation in lung cells have come mostly from rabbit and rat lungs, and
the generation of ROS has also been investigated in human alveolar macrophages
(Kinnula et al. 1995). Production of ROS is increased as a result of exposure to
high oxygen concentrations and to exogenous oxidants like ozone, asbestos
fibers, cigarette smoke, radiation, and certain drugs (Freeman and Crapo 1982,
Sibille and Reynolds 1990, Crystal 1991, Kamp et al. 1992). Superoxide
generation in the mitochondrial respiratory chain is associated with NADH
dehydrogenase and the ubiquinone cytochrome b complex (Freeman and Crapo
1982). Findings of increased mitochondrial ROS generation after exposure to
hyperoxia suggest that mitochondria are an important source of ROS production
in the lung (Freeman and Crapo 1981, Turrens et al. 1982). Superoxide
generation is highest when the respiratory chain carriers located in the inner
mitochondrial membrane are greatly reduced (Freeman and Crapo 1982).
Mitochondrial H2O2 is mainly derived from the dismutation of O2-
..
Approximately 1 to 2% of the oxygen consumed by the mitochondria is estimated
to be converted to O2-
. and H2O2.
Cell cytoplasm is also an important site of ROS production. One
non-enzymatic source of ROS is the generation of OH. by iron-catalyzed
reactions (Fenton and Haber-Weiss reactions), and in addition, ROS are formed
by intracellular enzymes. Xanthine oxidase (XO) is a cytoplasmic enzyme which
under normal conditions is in its dehydrogenase form with no detectable ROS
generation. In ischemic tissues, it is converted to oxidase, leading to the
production of O2-
. and H2O2 during reoxygenation (McCord 1985). Because the
level of XO in lung tissue is low, its role in ROS production is probably not
significant (Linder et al. 1999). Neutrophils contain myeloperoxidase, which in
the presence of halide ions converts H2O2 to hypochlorous acid (HOCl), a relative
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long-lived oxidant (Halliwell and Gutteridge 1989). Other sources of ROS
possibly relevant in the lung are microsomal cytochrome P-450 enzymes and
peroxisomal oxidases.
Reactive oxygen species play an important role in the host defense
against microbicidal agents. During phagocytosis, activated inflammatory cells
generate ROS through membrane-bound NADPH oxidase - the phenomenon
called respiratory burst (Babior 1984). Respiratory burst is induced by various
endogenous and extracellular factors such as opsonized bacteria, endotoxin,
cytokines, fibrous material, phorbol esters, and formyl-methionyl-leucyl-
phenylalanine (FMLP) (Rossi 1986). Recent studies have detected NADPH
oxidase not only in inflammatory cells but also in endothelial cells (Jones et al.
1996).
1.3. Comparison of ROS production between various cells types in the lung
The major sources and the amount of ROS produced vary between species and
organs. Although comparison of ROS production between cells is difficult, some
studies which have quantified the generation of ROS in various cell types of the
lung. The amount of H2O2 released by stimulated neutrophils is an order of
magnitude higher than that of monocytes (Ruch et al. 1983). Unstimulated rat
alveolar macrophages release H2O2 at a rate of 3.1 nmol/min/mg protein; rat type
II pneumocytes, 0.7 nmol/min/mg protein; and cultured endothelial cells, 0.06
nmol/min/mg protein (Kinnula et al. 1991). Rat pleural mesothelial cells generate
minor amounts of H2O2 extracellularly (less than 0.1 nmol/min/mg) (Kinnula et
al. 1992c).
Exposure to hyperoxia enhances the formation of ROS in rat lung
homogenates, in isolated rat lung mitochondria, and in rat alveolar macrophages
(Freeman and Crapo 1981, Freeman et al. 1982, Jamieson et al. 1986, Kinnula et
al. 1992d). Generation of H2O2 by bovine vascular endothelial cells is dependent
on oxygen tension, but it is already saturated at low concentrations (10% O2)
(Kinnula et al. 1993). Adult rat lung microsomes and mitochondria produce more
ROS than do organelles isolated from neonatal lungs, indicating that ROS-
generation is age-dependent (Frank 1991).
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1.4. Effects of ROS
Reactive oxygen species are potentially harmful, because they interact with each
other and modify cellular biomolecules (Figure 1). Lipid peroxidation is a
radical-mediated chain reaction initiated by abstraction of a hydrogen atom from
a polyunsaturated lipid and terminated by chain-breaking antioxidants such as α-
tocopherol (Halliwell and Gutteridge 1989). Hydroxyl radical, ROO., RO., and
some iron complexes, but not O2-
. or H2O2, are sufficiently reactive to initiate
lipid peroxidation. Excessive peroxidation of membrane lipids disrupts the
bilayer arrangement, decreases membrane fluidity, increases membrane
permeability, and modifies membrane-bound proteins.
Reactive oxygen species can damage DNA, proteins, and
carbohydrates. Radicals induce DNA strand breaks as well as oxidation of purine
and pyrimidine bases, and increase the occurrence of mutations (Freeman and
Crapo 1982). The appearance of DNA strand breaks activates poly-ADP-ribose
polymerase, a DNA repair enzyme, which leads to depletion of nicotinamide
adenine dinucleotide (NAD), depletion of adenosine triphosphate (ATP), and
alteration in energy balance (Schraufstatter et al. 1986, Hyslop et al. 1988). In
addition, ROS can activate or inactivate proteins by oxidizing sulfhydryl groups
and modifying amino acids (Davies 1987, Davies and Delsignore 1987).
O2
e- e- e- e-
O2-.
NO.
ONOO-
2H+
H2 O2 OH.
H+
H2 O
H2 O
H+
Cu+, Fe2+
OH.
Protein-, lipid-, and DNA-based
radicals and oxidative changes
in lipids, proteins and DNA
Oxidation of lipids,
proteins and DNA
Figure 1: Effects of reactive oxygen species.
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Severe oxidative stress with lipid peroxidation, protein oxidation,
DNA damage, and ATP depletion leads to cell death by necrosis, which is
characterized by disruption of the cell membrane and cellular organelles. Another
mechanism of cell death is apoptosis, a complex cell-suicide mechanism which is
beyond the scope of the present study. It has to be emphasized, however, that
ROS and changes in the cellular redox state, especially at the level of the
mitochondria, may play an important role in regulating and initiating reactions
closely associated with apoptosis (Kroemer et al. 1998, Mignotte and Vayssiere
1998).
Although most interest has focused on the damaging effects of ROS,
they also have beneficial effects on cells. The importance of ROS as a defense
mechanism against microbes has already been mentioned. NO. acts as a relaxing
factor in the vascular endothelium (Moncada and Higgs 1993). Moreover, ROS
have been shown to play a critical role in redox-regulation of gene expression
(Sen and Packer 1996), and in cell growth and proliferation (Burdon 1996).
1.5. Lung injury caused by ROS
In the normal lung, the upper airways are lined by pseudostratified ciliated
columnar cells, goblet and basal cells. In the distal airways, the epithelium
becomes progressively thinner and simplifies, with ciliated and Clara cells
predominating. The alveolar epithelium is composed of type I pneumocytes that
cover over 90% of the surface area, and cuboidal type II pneumocytes about
equal in number. Type II pneumocytes are producers of surfactant and capable of
cell division is why they act as progenitor cells of the alveolar epithelium. The
respiratory epithelium is covered by epithelial lining fluid containing
inflammatory cells, alveolar macrophages, T-lymphocytes, and neutrophils,
which play a central role in the defense of the lung. Alveolar macrophages are the
predominant cells in the alveolar space, >90% of the cells being macrophages.
The pleural mesothelium is covered by a single layer of epithelial cells, called
mesothelial cells (Crystal 1991).
The lung is the organ most severely damaged by exposure to
hyperoxia. Morphological changes in response to high oxygen tension are very
similar among different animals (Crapo 1986, Klein 1990) (Figure 2). Exposure
of rats to a lethal dose of hyperoxia (e.g. 100%) is associated with an initiation
phase (first 24 to 72 h) with no morphological changes but with increased
production of ROS (Freeman et al. 1982). The earliest morphological changes in
the hyperoxic rat lung are changes in endothelial cell structure, leading to
increased capillary permeability (Crapo et al. 1980). This is followed by
accumulation of inflammatory blood cells (platelets and neutrophils) into
intravascular and interstitial spaces (Barry and Crapo 1985) and release of
inflammatory mediators. The final stage of lethal oxygen toxicity is a destructive
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phase with endothelial cell damage after 80 h of hyperoxic exposure. No changes
in the number of type I or II pneumocytes are observed in rats, but after 4 days of
hyperoxia exposure in monkeys, there is almost complete destruction of type I
pneumocytes and hyperplasia of type II pneumocytes (Kapanci et al. 1969). The
progression of lung damage is basically similar in sublethal hyperoxia (60-85%
O2), but the onset of the various phases is delayed for up to a week. Proliferation
of type II pneumocytes and fibroblasts leads to interstitial fibrosis and
development of pulmonary hypertension due to thickening of the walls of
pulmonary arteries (Crapo et al. 1980). The most common early manifestations of
pulmonary oxygen toxicity in humans are symptoms of tracheobronchitis,
occurring as early as 3 h but usually within 12 to16 h of exposure to >95% O2
(Deneke and Fanburg 1980, Davis et al. 1983, Crapo 1986, Erzurum et al. 1993).
Time
Initiation
Su
bl
et
ha
l
Le
th
al
Inflammatory
Destructive
Death
Onset of endothelial cell injury
Recruitment of inflammatory cells
Release of inflammatory mediators
Endothelial cell destruction
Type I pneumocyte injury
Type II pneumocyte proliferation
Initiation
Inflammatory
Destructive
Type II pneumocyte proliferation
Fibroplast proliferation
Proliferative
Fibrosis
Figure 2: Relative time course of each phase of lung injury caused by lethal and
sublethal exposure to hyperoxia. Metabolic events associated with initiation of lung
injury cause no morphologic changes (see text). These metabolic events continue
throughout most or all of the duration of exposure to hyperoxia. Modified from Crapo
1986.
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2. Antioxidant defense mechanisms
Cells contain several antioxidant defense mechanisms to prevent injury. Lung
cells differ profoundly in their resistance to oxidant stress, which may be due to
differences in their antioxidant capacity or in the balance between oxidants and
antioxidants in these cells. These enzymatic and non-enzymatic antioxidant
defenses are discussed below. However, prevention of ROS formation and repair
of oxidative damage are also essential for the survival of aerobic organisms.
Sequestration of transition metals, e.g., by binding to storage and transport
proteins, minimizes the ”free” iron within the cells and prevents the formation of
highly reactive radicals (Fridovich and Freeman 1986, Heffner and Repine
1989).
2.1. Superoxide dismutases
Superoxide dismutases are metalloenzymes which catalyze the dismutation of O2-
.
to H2O2 and O2 at a rate 104 times as fast as than spontaneous dismutation at
neutral pH (Halliwell and Gutteridge 1989). Three different kinds of SODs have
been characterized in eukaryotes; a copper- and zinc-containing form
(CuZnSOD) localized in the cytosol, a manganese-containing form (MnSOD) in
the mitochondria (Fridovich 1986, Tsan 1997), and a copper- and zinc-containing
form in the extracellular matrix (ECSOD) (Marklund 1982). SOD has been
shown to play a central role in protecting cells and tissues against oxidant stress
(Fridovich and Freeman 1986, Tsan 1997).
Copper-zinc superoxide dismutase, a homodimer with a molecular
weight of ca. 32 000, was found by McCord and Fridovich (1969). CuZnSOD is
mainly localized in the cytosol, but is also found in the nucleus and peroxisomes,
at least in human cells (Crapo et al. 1992). CuZnSOD contains both Cu(II) and
Zn(II) at its active sites. CuZnSOD is encoded by a single gene located on
chromosome 21. In human cells are found two mRNA transcripts (0.7 and 0.9 kb)
(Sherman et al. 1984).
Manganese superoxide dismutase, which constitutes approximately
10 to15% of total cellular SOD activity, is a homotetramer with a molecular
weight of ca. 88 000 (Fridovich and Freeman 1986). MnSOD, having manganese
(III) at its active site, is localized in the matrix of the mitochondria, this location
being optimal for removal of O2-
. produced by the respiratory chain. The human
MnSOD gene, on chromosome 6, is transcribed into two major mRNA species of
4 and 1 kb having identical coding regions but different lengths of their 3’
untranslated regions (Wispe et al. 1989, Church et al. 1992). MnSOD activity can
be distinguished from that of CuZnSOD by its resistance to 1 mM potassium
cyanide or by the difference between their pH optima. The activity of CuZnSOD
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is approximately 10 times as great at pH 10 as at pH 7.8, whereas MnSOD is only
twice as active at the higher pH.
Extracellular superoxide dismutase is a secretory tetrameric Cu/Zn-
containing glycoprotein, with a molecular weight of around 135 000 (Marklund
1982). ECSOD is the least abundant of the SODs in tissues, but it is the major
SOD in extracellular fluids such as plasma and extracellular matrix (Marklund
1984, Sandstrom et al. 1993, Oury et al. 1994). Although most animals have
relatively high ECSOD activity in their lungs compared with other tissues,
ECSOD accounts for only 5 to 10% of total lung SOD activity (Marklund 1984).
2.2. Catalase
Catalase, a tetrameric hemoprotein with a molecular weight of 240 000,
decomposes H2O2 to water and oxygen. Catalase is mainly localized in the
peroxisomes (Davies et al. 1979), but is also found in the cytosol of human
neutrophils (Ballinger et al. 1994) and in rat-heart mitochondria (Radi et al.
1991). The Michaelis-Menten constant (Km) of catalase is higher than the Km of
glutathione peroxidase (GPx), which suggests that catalase scavenges H2O2
efficiently at high H2O2 concentrations (Jones et al. 1981).
2.3. Glutathione redox cycle
The glutathione redox cycle is a mechanism which scavenges lipid peroxides and
H2O2 (Figure 3). The enzymes in the cycle include glutathione peroxidase (GPx)
and glutathione reductase (GR). Glutathione peroxidase is a tetrameric
selenoprotein which uses reduced glutathione as cosubstrate. Its molecular weight
is 85 000. Glutathione peroxidase is localized in the cytosol and mitochondria, at
least in rat liver and in human fibroblasts (Mbemba et al. 1985, Behne et al.
1990), with a distinct form found in human plasma (Takahashi et al. 1987). Two
other known forms of GPx are selenium-dependent GPx in the intestine (Chu et
al. 1993) and phospholipid hydroperoxide GPx (Schuckelt et al. 1991). The
regeneration of glutathione through GR requires NADPH, which in turn is
regenerated through glucose-6-phosphate dehydrogenase (G6PDH) (Figure 3)
(Halliwell and Gutteridge 1989). The glutathione cycle is complementary to
catalase in scavenging H2O2. The Km value of GPx for H2O2 is lower than that for
catalase, and in contrast to catalase, GPx also reduces lipid peroxides.
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GSH
GSSG
H2O2NADP
2 H2ONADPH
GPxGRBCNU
Reduced glutathione
Oxidized glutathione
Glutamate
Cysteine
γ-GCS
GST
Thioether conjugates
G6PDH
Glycine
GSH synthetaseBSO
CDNB
Figure 3: Glutathione redox cycle modified from Harlan et al. 1984. γ-GCS: γ-
glutamylcysteine synthetase, GST: glutathione S-transferase, G6PDH: glucose-6-
phosphate dehydrogenase, GR: glutathione reductase, GPx: glutathione peroxidase,
BSO: buthionine sulfoximine, CDNB: 1-chloro-2,4-dinitrobenzene, BCNU: 1,3-bis(2-
chloroethyl)-1-nitrosourea.
2.4. Antioxidant enzymes in the lung
The localization of different AOEs in airways and in lung parenchyma has been
investigated by immunohistochemistry and by in situ hybridization, both
performed on tissue biopsies and freshly isolated cells derived in most cases from
rat lungs (Coursin et al. 1992, Kinnula et al. 1992a, Kinnula et al. 1992c, Clyde et
al. 1993, Oury et al. 1994, Chang et al. 1995). CuZnSOD has been shown to be
expressed throughout the lung, the highest levels in normal rats being in the
bronchial epithelium (Coursin et al. 1992, Chang et al. 1995, Gilks et al. 1998).
The expression of MnSOD in healthy lung appears to be low. In situ
hybridization of normal rat lung has revealed a consistent pattern of MnSOD
mRNA distribution in the lung, the most prominent labeling occurring in the
septal tips of alveolar ducts, around arterioles near airways, in alveolar type II
pneumocytes, and mesothelial cells (Clyde et al. 1993). According to
immunohistochemical studies, MnSOD protein is present in the mitochondria of
all rat lung cells, with the highest staining in type II epithelial cells and bronchial
epithelium (Coursin et al. 1992, Chang et al. 1995). Comparison of the enzyme
activities of rat alveolar type II pneumocytes and alveolar macrophages has
shown that the activity of MnSOD is higher in alveolar macrophages (Housset et
al. 1991). Both of these SODs are expressed at low levels in human bronchial
epithelium, alveolar type II pneumocytes, and alveolar macrophages (Kinnula et
al. 1994, Coursin et al. 1996, Lakari et al. 1998).
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Extracellular SOD mRNA is found in airway epithelial cells, type II
pneumocytes, and fibroblasts of human lung (Su et al. 1997). After its synthesis,
ECSOD is secreted, and the ECSOD protein is primarily localized around larger
vessels and airways, and to a lesser degree in the intercellular junctions of
epithelial cells, and around smooth muscle cells (Oury et al. 1994). Furthermore,
rat macrophages and neutrophils invading the lung during inflammation have
shown intensive staining for ECSOD protein (Loenders et al. 1998).
Rat alveolar type II pneumocytes, Clara cells, and alveolar
macrophages contain large amounts of catalase, whereas endothelial cells and
pleural mesothelial cells have very low catalase protein labeling and activity
(Kinnula et al. 1991, Kinnula et al. 1992c). In healthy human lung, catalase is
mainly expressed in alveolar type II pneumocytes, and to a lesser degree in the
bronchial epithelium and alveolar macrophages (Erzurum et al. 1993, Yoo et al.
1994, Coursin et al. 1996, Lakari et al. 1999). Very little is known about the
expression of the glutathione cycle enzymes in the lung. Glutathione peroxidase
mRNA and protein are expressed in the alveolar and bronchial epithelia of rat
lung. However, the most prominent labeling of GPx protein is seen in the
extracellular connective tissue of the lung (Coursin et al. 1992, Gilks et al. 1998).
Only one study is available on human lung, where the distribution of GPx protein
has been investigated. In that study the GPx was localized in the respiratory
epithelium (Coursin et al. 1996). Because the activity of catalase, as well as other
AOEs, decreases during in vitro culture (Panus et al. 1989, Kinnula et al. 1992a),
the results obtained in culture models cannot, therefore, be used in assessment of
the levels of various AOEs in human lung.
2.5. Regulation of AOEs in the lung
The regulation of pulmonary AOEs in response to hyperoxia is complex and has
been intensively studied in experimental animals (Crapo and Tierney 1974,
Freeman et al. 1986, Baker et al. 1989). Exposure of adult rats to 85 to 95%
oxygen results in increased mRNA expression of MnSOD (Clerch and Massaro
1993, Ho et al. 1996) and GPx (Ho et al. 1996), but catalase and CuZnSOD
mRNAs remain unchanged (Clerch and Massaro 1993, Ho et al. 1996).
Simultaneously, the specific activities of these AOEs have been found to increase
in some, but not all studies (Kimball et al. 1976, Freeman et al. 1986, Clerch and
Massaro 1993, Ho et al. 1996). MnSOD activity in alveolar type II pneumocytes
is significantly increased in rats exposed to sublethal hyperoxia (85%) (Freeman
et al. 1986). In situ hybridization has shown that a major difference in the
distribution of MnSOD mRNA between air- and hyperoxia-exposed rat lung
occurs at the pleura (Clyde et al. 1993). However, hyperoxia in vitro does not
increase AOE levels or activities in rat or rabbit alveolar epithelial cells (Panus et
al. 1989, Housset et al. 1991). Furthermore, recent studies with human bronchial
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epithelial cells have shown that total SOD and catalase activities do not increase,
or the increase is not sufficiently high enough for cell protection after acute
hyperoxia exposure in vivo or in vitro (Erzurum et al. 1993, Yoo et al. 1994).
The regulation of AOEs under oxidant conditions is more complex in
vivo than in vitro. The mRNA expression, protein concentrations, and enzyme
activities do not correlate with each other (Jornot and Junod 1992, Clerch and
Massaro 1993). The induction of MnSOD in rat lungs in vivo is maximal at days
3 to 5 of hyperoxia exposure (Ho et al. 1996), which is also the time required for
the recruitment of activated inflammatory cells into the lungs (Barry and Crapo
1985). It can therefore be hypothesized that AOE induction in the lung is related
to cytokine release and inflammation rather than to the high oxygen tension itself.
It has to be emphasized that the effects of inflammatory cytokines and
inflammation are associated with an increased oxidant burden at the cellular
level. Manganese superoxide dismutase mRNA or protein or both are induced by
several cytokines and oxidants. These include tumor necrosis factor α (TNF-α)
(Wong and Goeddel 1988, Tsan et al. 1990b, Visner et al. 1990, Warner et al.
1991, Visner et al. 1991), interferon-γ (IFN-γ) (Harris et al. 1991), interleukin-1
(IL-1) (Masuda et al. 1988, Visner et al. 1990, Tsan et al. 1991), endotoxin
(Visner et al. 1990, Visner et al. 1991, Clerch and Massaro 1993, Tang et al.
1994), cigarette smoke (Gilks et al. 1998), and various oxidants, such as H2O2,
thioredoxin, and peroxynitrite (Das et al. 1995, Warner et al. 1996, Jackson et al.
1998). Furthermore, exposure to asbestos fibers or to various fibrogenic materials
has been shown to induce MnSOD in tracheal epithelial cells (Mossman et al.
1986) and in alveolar type II pneumocytes in vivo (Holley et al. 1992), and cause
MnSOD mRNA upregulation in mesothelial and bronchial epithelial cells in vitro
(Janssen et al. 1994a, Marks-Konczalik et al. 1998). It should be pointed out that
in contrast to in vitro studies, in which only MnSOD is induced after cytokine
exposure, in rats treated with cytokines and hyperoxia the activities of lung
CuZnSOD, GPx, and catalase are also induced (White et al. 1989, Tsan et al.
1990a). In addition, ECSOD is upregulated by lipopolysaccharide but not by
hyperoxia (Loenders et al. 1998). Most of these studies have been conducted on
animal cell models or on various malignant cell lines.
2.6. Importance of AOEs in oxidant defense
Considerable evidence supports the importance of AOEs in pulmonary defense
against oxygen toxicity. Animals pre-exposed to sublethal hyperoxia have shown
resistance to consequent exposure to 100% O2, and this resistance correlates with
increased total SOD activity (Crapo and Tierney 1974). Tracheal insufflation of
liposome-encapsulated or polyethylene glycol (PEG) -conjugated CuZnSOD or
catalase or both protects rats against oxygen toxicity (Freeman et al. 1985,
Padmanabhan et al. 1985, Tang et al. 1993). Genetic manipulation that causes an
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elevation in or an absence of expression of SODs results, respectively, in
increased or decreased tolerance to O2 (Hassan 1988). Antisense oligonucleotides
to MnSOD increase the sensitivity of leukemic cells to the growth-inhibitory
effects of TNF-α (Kizaki et al. 1993). Transfection of cultured rat lung L2 cells
with human CuZnSOD cDNA protects against xanthine/XO-induced cytotoxicity
(Komada et al. 1996). Furthermore, tracheal insufflation of endotoxin, TNFα, or
IL-1 results in prolonged survival of adult rats during hyperoxia exposure, with a
simultaneous increase in AOEs, most prominently MnSOD (Tsan et al. 1990a,
Tsan et al. 1991, Clerch and Massaro 1993). On the other hand, resistance to
hyperoxia in vivo is not necessarily related to changes in lung AOEs (Baker et al.
1989).
The possible mechanisms by which endotoxin, cytokines, and
hyperoxia enhance MnSOD mRNA are by increased rate of transcription (Visner
et al. 1991) or increase in the stability of MnSOD mRNA (Clerch and Massaro
1993). The transient fall in MnSOD activity during exposure to O2 seen in some
studies seems to be due to impaired translational efficiency and to a post-
translational effect, i.e., low MnSOD-specific activity (Clerch et al. 1998).
It has been suggested that cytokine-induced MnSOD protects cells
and tissues during oxygen exposure in vivo and in vitro (Wong et al. 1989,
Warner et al. 1991, Lewis-Molock et al. 1994, Tsan 1997), but contradictory
results with vascular endothelial cells have also been obtained (Marcho et al.
1991). The combination of different AOEs may be more important than any
individual enzyme (Amstad et al. 1991, Amstad at al. 1994). For example,
tolerance to hyperoxia of transgenic mice overexpressing CuZnSOD is associated
with increased activity of GPx (White et al. 1991). It should also be noted that
H2O2-scavenging enzymes are increased simultaneously with MnSOD induction
(Freeman et al. 1986, Jornot and Junod 1992).
Recent studies with genetically manipulated mice have provided
further information about the importance of AOEs in resistance to oxygen
toxicity. Transgenic mice that overexpress MnSOD in alveolar type II
pneumocytes and in non-ciliated bronchial epithelial cells are tolerant to
hyperoxia (Wispe et al. 1992). Homozygous MnSOD knock-out mice die within
the first 10 days of life with a dilated cardiomyopathy, accumulation of lipid in
the liver and in skeletal muscle, and metabolic acidosis (Li et al. 1995).
Heterozygous knock-outs are viable, and are not more susceptible to 100%
oxygen than are their normal littermates (Tsan et al. 1998). Transgenic mice,
which constitutively express elevated levels of human CuZnSOD, have, upon
exposure to hyperoxia, shown increased survival and decreased morphological
evidence of lung damage (White et al. 1991), but for unknown reasons, this
protective effect has been noted only in a subgroup of young, female transgenic
mice. Contradictory results have also been obtained: no protection against
hyperoxia in transgenic mice overexpressing CuZnSOD or MnSOD (Ho et al.
1998). Knockout mice lacking ECSOD develop normally, but are more
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susceptible to the toxic effects of oxygen (Carlsson et al. 1995), whereas
transgenic mice overexpressing ECSOD, when exposed to hyperoxia, show
decreased morphological evidence of lung damage and a reduced number of
recruited inflammatory cells than do wild-type mice (Folz et al. 1999). Due to its
ideal localization in the areas where O2-
. is released by phagocytic leukocytes,
ECSOD may be important in protecting cell surfaces and extracellular matrix
proteins from superoxide-mediated damage.
Catalase and the glutathione-redox cycle are two H2O2-scavenging
pathways. Glutathione plays an important role in maintaining intracellular redox
balance and in cellular defense against oxidative stress (Rahman et al. 1995).
Glutathione is present in high concentrations in human lung epithelial lining fluid
(Cantin et al. 1987). Extracellular glutathione has also been shown to protect rat
alveolar macrophages against hyperoxia, and that this protection is abolished by
an inhibitor of γ-glutamyl transpeptidase suggest the importance of the
glutathione cycle in alveolar macrophage protection (Forman and Skelton 1990).
Furthermore, pulmonary depletion of glutathione in lungs of mice or rats
exacerbates oxygen toxicity (Deneke et al. 1985, Smith et al. 1990), and
intraperitoneal supplementation of glutathione protects preterm rabbits against
oxidant stress (Brown et al. 1996). Inhibition of glutathione synthesis by
buthionine sulfoximine (BSO) increases hyperoxic cell injury in rat type II
pneumocytes in vitro (Aerts et al. 1992). The significance of H2O2-scavenging
pathways varies considerably in different cell types. Human alveolar
macrophages and freshly isolated rabbit or rat type II pneumocytes protect
themselves against exogenous H2O2 mainly by a catalase-dependent pathway
(Engstrom et al. 1990, McDonald et al. 1991, Kinnula et al. 1992a). On the other
hand, vascular endothelial cells or pleural mesothelial cells, both of which
contain low AOE levels (Kinnula et al. 1991, Kinnula et al. 1992c), are protected
against exogenous H2O2 mainly by the glutathione redox pathway (Harlan et al.
1984, Suttorp et al. 1986, Kinnula et al. 1992c). In addition, we have previously
shown that the glutathione cycle is important in maintaining intracellular energy
metabolism and protecting the cell membrane against oxidant damage in human
bronchial epithelial cells (Aalto et al. 1996).
2.7. Nonenzymatic antioxidants
A number of compounds act as non-enzymatic antioxidants. α-tocopherol
(vitamin E) is lipophilic, and its major role is to block the chain reaction of lipid
peroxidation (Sies et al. 1992). Pre-treatment with vitamin E has been shown in
rabbits to prevent lung injury caused by hyperoxia (Jacobson et al. 1990). α-
tocopherol and ascorbic acid (vitamin C) cooperate in cellular defense against
ROS. Ascorbic acid reduces the oxidized α-tocopheryl radical back to α-
tocopherol (Freeman and Crapo 1982). In addition, vitamin C, a hydrophilic
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scavenger of ROS, is considered the most important antioxidant in extracellular
fluids (Sies et al. 1992). On the other hand, ascorbic acid can promote ROS-
injury in the presence of free transition metals (Heffner and Repine 1989).
Dietary carotenoids and ubiquinol are also thought to act as antioxidants, but their
precise role in vivo is unclear (Halliwell and Gutteridge 1990). In addition to
being essential in the glutathione redox cycle, glutathione can scavenge ROS
non-enzymatically (Freeman and Crapo 1982), as well as detoxify xenobiotics via
the glutathione S-transferase reaction. Glutathione protects SH-groups of proteins
from oxidation and maintains vitamin-C levels (Meister 1992). The precursor of
glutathione, N-acetyl-cysteine, scavenges ROS and has been used in various
clinical trials (Aruoma et al. 1989, Bernard et al. 1997).
3. Clinical implications of antioxidant defense in the lung
3.1. Adult respiratory distress syndrome (ARDS)
Adult respiratory distress syndrome (ARDS) is characterized by neutrophil
accumulation, diffuse pulmonary infiltrates, and pulmonary edema, and in
mechanically ventilated patients its severity is increased by the use of high
oxygen tensions. It has been suggested that increased production of ROS by
activated neutrophils combined with decreased antioxidant capacity plays a
central role in the pathogenesis of ARDS (Chabot et al. 1998). Patients with
ARDS have elevated concentrations of H2O2 in their exhaled air (Sznajder et al.
1989), and the serum of ARDS patients scavenges H2O2 more efficiently than
that of patients without ARDS, a finding associated with the increased AOE
activities in the serum of ARDS patients (Leff et al. 1992, Leff et al. 1993). The
glutathione content of alveolar lining fluid is decreased in ARDS (Pacht et al.
1991), and ARDS patients show significantly lower plasma levels of non-
enzymatic antioxidants such as α-tocopherol (Metnitz et al. 1999).
3.2. Inflammatory airway diseases
In the pathogenesis of chronic obstructive pulmonary disease (COPD), generation
of ROS by activated inflammatory cells plays a central role. Cigarette smoke
itself contains ROS. One puff of cigarette smoke has been estimated to contain
1015 radicals (Church and Pryor 1985). Cigarette smoke also contributes to the
recruitment of inflammatory cells to the airways. Furthermore, this inflammation
is stimulated by other inhaled pollutants and by cytokines. A protease-
antiprotease imbalance plays an important role in the progression of COPD, but
an imbalance between oxidants and antioxidants has also been proposed as
playing a role in the pathogenesis of this disease (Rahman and MacNee 1996).
The data on AOE activities in the lung of cigarette smokers are contradictory.
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Alveolar macrophages of smokers and smoke-exposed hamsters have increased
activities of SOD and catalase, with no change in GPx (McCusker and Hoidal
1990). Catalase and GPx activities in the bronchoalveolar lavage (BAL) cells
from smokers are increased, without any difference in SOD activity (Hilbert and
Mohsenin 1996). Another study reports that SOD activity of BAL fluid is lower
in smokers than in controls (DiSilvestro et al. 1998), and that increased
production of O2-
. by alveolar macrophages of elderly smokers is associated with
a post-translationally modified reduction in AOE activities when compared to
those of nonsmokers (Kondo et al. 1994). The mRNA expression of MnSOD is
transiently increased in bronchial epithelial cells of smoke-exposed rats. After
prolonged exposure, the mRNA level of GPx is also elevated (Gilks et al. 1998).
Bronchial asthma is defined by reversible airflow obstruction, by
bronchial hyper-responsiveness, and by chronic inflammation characterized by
influx and activation of inflammatory cells and epithelial cell damage (Barnes
1990). Cells obtained from the peripheral blood and lungs of patients with asthma
generate increased amounts of ROS (Vachier et al. 1992, Jarjour and Calhoun
1994, Kinnula et al. 1995, Majori et al. 1998). In contrast to what might be
expected, peripheral blood cells from asthmatic patients exhibit reduced or
unchanged antioxidant defense including reduced GPx and SOD activities
(Vachier et al. 1992, Joseph et al. 1993, Misso et al. 1998). In addition, it has
recently been shown that in the airway epithelium of asthmatic patients,
CuZnSOD, but not catalase or GPx, is decreased (De Raeve et al. 1997, Smith et
al. 1997). Decreased antioxidant defense in the airways of asthmatic patients may
be associated not only with the increased oxidant burden but also with the
epithelial injury of these patients.
3.3. Interstitial lung diseases
Reactive oxygen species may play a central role in the pathogenesis of a variety
of interstitial lung diseases such as idiopathic pulmonary fibrosis (usual
interstitial pneumonia, UIP, and desquamative interstitial pneumonia, DIP),
asbestosis, and granulomatous lung diseases (sarcoidosis and allergic alveolitis).
Alveolar macrophages from patients with pulmonary fibrosis produce
significantly more O2-
. (Strausz et al. 1990). Furthermore, it has been found that
patients with idiopathic pulmonary fibrosis have higher serum CuZnSOD protein
levels than do controls, and that these levels correlate with disease severity (Borzi
et al. 1993). Recent studies conducted on human lung tissue have shown high
expression of MnSOD in the granulomas of pulmonary sarcoidosis and allergic
alveolitis (Lakari et al. 1998), and induction of MnSOD and consistent expression
of catalase in the well-preserved alveolar regions of various interstitial lung
diseases (Lakari et al. 1999). The role of ROS in the pathogenesis of asbestos-
related diseases is supported by the fact that asbestos fibers enhance ROS
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generation from inflammatory cells (Kamp et al. 1992), and that the AOEs,
especially MnSOD, are induced by asbestos fibers (Mossman et al. 1986, Holley
et al. 1992). In addition, treatment of rats with PEG-conjugated catalase reduces
lung injury caused by the fibers (Mossman et al. 1990).
3.4. Bronchopulmonary dysplasia (BPD)
At birth the infant is exposed to increased oxidative stress. Preterm infants are at
high risk for developing chronic lung disease: bronchopulmonary dysplasia
(BPD) (Saugstad 1998). Among factors playing an important role in its
development are prematurity, barotrauma, volutrauma, and oxygen toxicity. AOE
defense against high inspired oxygen levels after birth in preterm infants may be
poor, since many investigators have demonstrated that in various animals the
expression of MnSOD, CuZnSOD, catalase, and GPx increase toward term in the
fetal lung (Tanswell and Freeman 1984, Frank 1991, Clerch and Massaro 1992).
Very few studies have reported a similar profile, at least for catalase in human
ontogenesis (McElroy et al. 1992, Asikainen et al. 1998). When exposed to
hyperoxia, preterm rabbits and baboons (Frank and Sosenko 1991, Morton et al.
1999), but not rats or guinea pigs (Sosenko and Frank 1987, Chen et al. 1994), in
contrast to term rats, are unable to induce AOE activities in the lung. Not only
AOEs but also surfactant deficiency and ventilator treatment are factors
contributing to the development of BPD (Saugstad 1998). In experimental animal
models, the morphological changes in BPD, such as endothelial and epithelial
damage, alveolar disruption, bronchial smooth muscle hyperplasia, and hyaline
accumulation in alveolar spaces, as well as interstitial fibrosis, are also seen in
oxygen toxicity (Crapo 1986, Margraf et al. 1991). Moreover, inflammatory cells
which are recruited into the lungs (Margraf et al. 1991) can further enhance ROS
production, as well as induce the release of inflammatory cytokines. Therefore, it
is not surprising that the following results are in line with the cytokine- and
hyperoxia-induced MnSOD expression discussed previously. Pulmonary MnSOD
is significantly elevated in the lungs of baboons representing an animal model of
BPD, and the protein expression is regulated, at least partly, at the post-
transcriptional level (Clerch et al. 1996). In human BPD lungs, proliferating type
II pneumocytes and alveolar macrophages show intense staining for MnSOD
protein (Dobashi et al. 1993, Ohbayashi et al. 1997). Surfactant replacement,
antenatal steroid therapy, and more gentle ventilatory techniques have improved
the outcome for preterm infants, and new therapeutic approaches with
antioxidants and AOE supplementation have also given promising results,
although their use in practice needs further investigation.
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3.5. Therapeutic implications for improving antioxidant defense in the lung
Considerable effort has been made in recent years to enhance AOE activities and
oxygen tolerance by therapeutic utilization of antioxidants. Problems in the
protective role of various AOEs are their poor penetrance into cells and extremely
short plasma half-lives. Various manipulations of enzymes and means of delivery
have thus been tested. Premature infants are known to be deficient in glutathione
and selenium (Jain et al. 1995), but glutathione delivery by intravenous or
intratracheal routes has failed to raise cellular levels of glutathione, and has not
been shown to be protective (Meister 1991). N-acetylcysteine (NAC)
administration in adults with ARDS offers some evidence of reduced lung injury
(Bernard et al. 1997). A study on the treatment of preterm infants with NAC to
improve survival and prevent development of chronic lung injury is ongoing in
this hospital. In animals, intravenous or intratracheal administration of liposome-
encapsulated or PEG-conjugated SOD and catalase are able to moderate
hyperoxia- or asbestos fiber-induced lung damage (Freeman et al. 1985,
Padmanabhan et al. 1985, Mossman et al. 1990).
For genetically modified mice, SODs are critically important in
protecting the lung from the damaging effects of hyperoxia (Wispe et al. 1992,
Carlsson et al. 1995), and lung injury caused by hyperoxia can be prevented by
intratracheal administration of SOD (Padmanabhan et al. 1985, Davis et al. 1993,
Tang et al. 1993). Recent evidence indicates that SOD may have beneficial
effects in preventing lung injury also in humans. When preterm infants are treated
with intratracheally delivered recombinant SOD, the concentration and activity of
SOD increase in serum, intratracheal fluid, and urine, and the parameters of lung
injury decline (Davis et al. 1997). However, preliminary results of a controlled
clinical trial fail to suggest any beneficial effect (Davis et al. 1999). Molecular
biology has opened new avenues to manipulate genes and express a variety of
important proteins. Intratracheal injection of an adenovirus containing SOD and
catalase cDNAs have been used successfully to increase enzyme expression in
airway epithelium and alveolar macrophages, and thus prevent rats from
hyperoxia- or irradiation-induced lung damage (Danel et al. 1998, Epperly et al.
1999).
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AIMS OF THE STUDY
The formation of ROS and the consequent oxidative stress has been suggested to
be important in the pathogenesis of various lung diseases. Because the
antioxidant enzyme system is a primary defense mechanism of the lung, this
present study was designed to investigate the role and regulation of the most
important AOEs in human lung cells by exposing the cells to agents and states
which may play an important role in the pathogenesis of lung diseases (cytokines,
asbestos fibers, and hyperoxia). Furthermore, the study investigated the protective
role of various AOEs in different cell types of the human lung. The specific aims
were to investigate:
1)  the effect of cytokines (TNF-α and IFN-γ) on MnSOD induction and oxidant-
related cytotoxicity in human bronchial epithelial cells (I)
2)  the effect of hyperoxia on various antioxidant pathways and on oxidant-related
cytotoxicity in human bronchial epithelial cells (II)
3)  the effect of asbestos fibers and cytokines on MnSOD induction and oxidant-
related cytotoxicity in human pleural mesothelial cells (III)
4)  the importance of different AOE pathways in oxidant-related cytotoxicity of
alveolar macrophages (IV)
5)  and to compare different AOE pathways in human inflammatory cells and
assess their potential effects on cell survival and oxidant-related toxicity (V)
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MATERIALS AND METHODS
1. Cells and culture
1.1. Cell lines (I-III)
Transformed human bronchial epithelial cells (I, II), BEAS-2B, and transformed
human pleural mesothelial cells (III), MET-5A, were obtained from the National
Cancer Institute, Laboratory of Human Carcinogenesis (Dr. C. Harris, Bethesda,
MD, USA). BEAS-2B is an SV40-transformed epithelial cell line established
from healthy bronchial epithelium which has been shown to maintain typical
epithelial morphology and functional characteristics (Ke et al. 1988, Reddel et al.
1988). BEAS-2B cells contain lower AOE levels than do bronchial epithelial
cells in situ, but they express all AOEs, and are therefore an appropriate stable in
vitro model to investigate the role and the regulation of AOEs in epithelial cell
defense and injury (Kinnula et al. 1994). BEAS-2B cells were cultured on
uncoated 4-well tissue-culture plates or 35-mm petri dishes in serum-free
hormone-supplemented medium according to the manufacturer’s instructions
(bronchial epithelial growth medium, BEGM, Clonetics Inc., San Diego, CA,
USA). MET-5A is an SV40-transformed mesothelial cell line established from
healthy mesothelium. MET-5A cells exhibit features of mesothelial cells,
including sensitivity to the cytotoxic effects of asbestos fibers. Because they
remain nontumorigenic, they are therefore a useful model for in vitro studies of
fiber cytotoxicity (Ke et al. 1989). MET-5A cells were cultured on uncoated 24-
well tissue-culture plates or 35-mm petri dishes in RPMI-1640 medium (Gibco
Europe, Paisley, UK) containing 10% fetal bovine serum (FBS, Gibco), penicillin
(100 U/ml), streptomycin (100 µg/ml) (Gibco), and L-glutamine (Gibco).
1.2. Primary cell isolation and culture (IV-V)
Peripheral monocytes (V) were isolated from buffy coats (Finnish Red Cross,
Helsinki, Finland) by a modification of the method described by Böyum (1968).
Briefly, buffy coats were obtained 1-2 h after venipuncture. After dilution 1:3
with phosphate-buffered saline (PBS, Orion, Espoo, Finland) and mixing with a
glass rod, the cell suspension was layered over Ficoll-Paque (Pharmacia, Biotech
AB, Uppsala, Sweden) and centrifuged at 900 x g for 30 min. Mononuclear cells
were collected at the interface, washed twice with PBS, and suspended in the
standard medium of RPMI-1640 supplemented with L-glutamine, penicillin-
streptomycin, and 20% human AB-serum (Finnish Red Cross). Viability tested by
trypan blue exclusion was over 90%. Mononuclear cells were incubated in
collagen-coated 4-well tissue-culture plates or 35-mm petri dishes (Falcon,
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Becton Dickinson U.K. LTD, Plymouth, UK) for 1 h at 37ºC. After incubation,
non-adherent cells were removed by washing with PBS. Adherent cells were
cultured under 5% CO2 at 37ºC for up to 5 days in standard medium, which has
been shown to induce maturation of monocytes into so-called monocyte-derived
macrophages.
Neutrophils (V) were isolated from the heparinized venous blood of
healthy volunteers as previously described (Böyum 1968). Briefly, after
sedimentation with 3% dextran (Pharmacia), Ficoll-Paque centrifugation at 400 x
g for 40 min, and hypotonic lysis of red blood cells, neutrophils were suspended
in standard medium and pelleted immediately or cultured in 4-well tissue culture
plates or petri dishes for up to 24 to 72 h. Viability after isolation was over 90%.
Alveolar macrophages (IV, V) were isolated from bronchoalveolar
lavage fluid (BAL), obtained from patients with minor respiratory symptoms.
BAL was centrifuged at 330 x g, and the cells were washed twice with RPMI-
1640 medium. Cytocentrifuge preparations indicated that over 90% of the cells
were macrophages. For further enrichment, cells were layered in petri dishes or 4-
well tissue-culture plates in RPMI-1640 medium containing 10% FBS (Gibco),
and incubated at 37ºC for 1 h or overnight. Non-adherent cells were removed by
washing.
Study protocols utilizing patients’ samples were approved by the
Ethics Committees of the Department of Internal Medicine, University of
Helsinki and the Finnish Red Cross.
2. Pretreatments and oxidant exposures (I-V)
2.1. Inactivation of AOEs (IV, V)
To assess the role of different antioxidant enzymes, the cells in culture media
were pretreated with  10 µM 1-chloro-2,4-dinitrobenzene (CDNB, E.Merck,
Darmstadt, Germany) for 40 min to conjugate glutathione (Buckley et al. 1991),
with 100-500 µM buthionine sulfoximine (BSO) (Sigma) for 6 h or 16 h to
inhibit γ-glutamylcysteine synthetase and deplete glutathione (Griffith and
Meister 1979), with 100 µg/ml 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) for
15 min to inhibit GR (Babson and Reed 1978), or with 30 mM aminotriazole
(ATZ) for 60 min to inactivate catalase (Margoliash et al. 1960). These
compounds were removed by washing with PBS before subsequent oxidant
exposures. All these inhibitors are widely used, and under these experimental
conditions, nontoxic.
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2.2. Exposures to cytokines (I-III), hyperoxia (I, II), and asbestos fibers (III)
Subconfluent cultures in standard media were exposed to 10 or 100 ng/ml
recombinant human tumor necrosis factor-α (TNF-α) (I-III), to 10 or 100 ng/ml
human recombinant interferon-γ (IFN-γ) (I), or to a combination of these
cytokines (I) each for 16 to 72 h, or to 2 µg/cm2 amosite asbestos fibers (AMOS)
(III) or to a combination of TNF-α and AMOS (III) each for 48 h. The cytokines
were provided by Boehringer Ingelheim, Europe (Vienna, Austria). In hyperoxia
experiments (I, II) the cultures were exposed to 95% O2 and 5% CO2 for 16 to 72
h. Subconfluent cells in culture medium were placed in a Plexiglas chamber
through which gas flow was adjusted so that the high oxygen concentration
remained stable during the incubation.
2.3. Oxidant exposures (I-V)
Control and pretreated cells were washed and subsequently exposed to 0.1 to 5
mM H2O2 (Merck AG, Darmstadt, Germany) for 2 to 4 h (I, II, IV, V), to 5 to 500
µM menadione (Sigma) for 2 to 4 h (I-III), to hyperoxia (95% O2) for 48 h, or to
10-7 M formyl-methionyl-leucyl-phenylalanine (FMLP, Sigma) for 2 h (IV, V).
The exact H2O2 concentration was determined spectrophotometrically using the
molar extinction coefficient of 44 M-1 cm-1 at 240 nm.
3. Measurement of enzyme activities (I-V) and glutathione concentrations
(II, V)
The cells were detached with trypsin-EDTA (Gibco), pelleted, and immediately
frozen at -80ºC until analysis. Total SOD activity (I, II, III, V) was assayed
spectrophotometrically by measuring the inhibition of the reduction of
cytochrome c in the xanthine oxidase reaction at 550 nm (McCord and Fridovich
1969). MnSOD activity was distinguished from CuZnSOD by its resistance to 1
mM potassium cyanide. Catalase activity (I, II, IV, V) was determined
polarographically by measuring the oxygen production rate with a Clark oxygen
electrode in a stirred chamber (Kinnula et al. 1992a). Glucose-6-phosphate
dehydrogenase (G6PDH) activity (I) was quantitated spectrophotometrically by
following the oxidation of NADP (Löhr and Waller 1974). GR activity (I, II, IV,
V) was analyzed by measuring the oxidation of NADPH at 340 nm in the
presence of oxidized glutathione (Beutler 1975), and GPx activity (I, II, IV, V) by
measuring NADPH oxidation at 340 nm in the presence of t-butylhydroperoxide,
glutathione, and GR (Beutler 1975). Enzyme activities are expressed as units per
milligram protein. Protein was determined by the method of Lowry et al (1951)
(I-IV) or by Bio-Rad DC assay (Bio-Rad Laboratories, Hercules, CA, USA) (V).
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For the analysis of total glutathione levels (II, V), the cells were collected
in 2 N perchloric acid containing 2 mM ethylenediamine tetra-acetic acid
(EDTA). After neutralization with a solution containing 2 M KOH and 0.3 M N-
morpholinopropanesulfonic acid (MOPS), total cellular glutathione content was
determined spectrophotometrically by measuring the reduction of 5,5'-
dithiobis(2-nitrobenzoic acid) (Sigma) by NADPH in the presence of glutathione
reductase (Sigma) (Akerboom and Sies 1981). Cellular glutathione content is
expressed as nmol/mg protein.
4. Northern blotting analysis (II, III, V)
Cells were collected in 4 M thiocyanate buffer, and the samples were frozen
immediately at -80°C. Total RNA was extracted from the cells by the acid
phenol-chloroform method (Chomczynski and Sacchi 1987). RNAs (10 or 20
µg/lane) were electrophoresed on a 1% agarose gel containing 0.36 M
formaldehyde. Samples were capillary transferred onto Hybond-N nylon filters
(Amersham International, Amersham, UK) and cross-linked to the filters by UV
illumination (UV Stratalinker 1800; Stratagene, La Jolla, CA, USA).
Prehybridization was done at 58.5°C for > 1 h. Filters were hybridized with 32P-
labeled cRNA probes representing nucleotides 596-987 of human MnSOD (Ho
and Crapo 1988), 127-457 of human CuZnSOD (Hallewell et al. 1985), 537-2218
of human catalase (Quan et al. 1986), or 533-624 of rat GPx (Ho et al. 1988),
each cloned into the pSP65 vector (Promega Co., Southampton, UK). The
transcripts were purified by NucTrap columns (Stratagene) and added to the
prehybridization solution at 2x106 cpm/ml. Hybridization was then carried out at
58.5°C overnight with shaking. After washing, autoradiography was performed at
-80°C by use of Kodak BioMax MR film (Eastman Kodak Co, Rochester, NY,
USA). Following autoradiography, the filters were rehybridized with a β-actin
control probe transcribed from pTRI-β-actin plasmid (Ambion, Austin, TX,
USA). Antioxidant enzyme mRNA expressions were quantified relative to actin
expression by a X-Rite 331 Transmission densitometer  (II, V) (X-Rite,
Grandville, MI, USA) or NIH Image 1.52 software (III). The  human MnSOD,
CuZnSOD, catalase, and rat GPx cDNAs were kindly provided by Dr. Y.-S. Ho,
Wayne State University, Detroit, MI, USA.
5. Western blotting analysis (I,V)
The cells were detached, centrifuged, and washed with PBS. The cell pellet was
mixed with the electrophoresis sample buffer and boiled for 5 min at 95oC. 50 or
75 µg of cell protein was applied per lane to a 10-12% sodium dodecyl sulfate
(SDS) -polyacrylamide gel (Laemmli 1970). The gel was electrophoresed for 1.5
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h (90 V) (V) or 3.5 h (40 mA) at room temperature, the protein was transferred
(45 min, 100 V or 3 h, 400 mA) onto Hybond ECL nitrocellulose membranes
(Amersham, Arlington Hights, IL, USA) in a Mini-PROTEAN II Cell (Bio Rad
Laboratories). The blotted membrane was incubated with rabbit antibody to
recombinant human MnSOD (1:10 000) (gift from Professor J.D. Crapo, National
Jewish Medical and Research Center, Denver, CO, USA), followed by donkey
anti-rabbit secondary antibody (V) or goat anti-rabbit immunoglobulin G (1:30
000) conjugated to horseradish peroxidase (Amersham). MnSOD was detected by
an enhanced chemiluminescence system (ECL, Amersham), and the luminol
excitation was imaged on X-ray film (Eastman Kodak). Cell protein was
determined by Bio-Rad DC assay (Bio-Rad Laboratories).
6. Immunohistochemistry (IV)
Immunolocalization of catalase was performed on sections of cell pellets from
freshly isolated and cultured macrophages. Cell pellets from four healthy
volunteers (two samples cultured, the other two freshly isolated) were fixed with
2% paraformaldehyde plus 0.2% glutaraldehyde in 0.1 M phosphate buffer (pH
7.4). After 1 h, they were transferred to 2% paraformaldehyde without
glutaraldehyde for an additional 24 h. Thereafter, the cells were washed three
times with PBS and incubated in 10% gelatin at 37°C for 10 min. Blocks were
cryoprecipitated with 2.3 M sucrose and frozen in liquid nitrogen. Cryoultrathin
sections were prepared with a cryomicrotome, and immunolabeling was done by
the method of Slot et al. (1986). Cells from each pellet were photographed, and
the number of gold particles on peroxisomes, cytoplasm, and nucleus counted.
The area occupied by these compartments was measured by point counting.
7. H2O2 consumption (II, IV)
H2O2 consumption by untreated and pretreated intact cells was analyzed
fluorometrically by following H2O2-dependent oxidation of 4-hydroxy-3-
methoxyphenylacetic acid (homovanillic acid, HVA, Sigma) in the presence of
horseradish peroxidase (HRP, Sigma) by the modified method (Kinnula et al.
1992d) of Ruch et al. (1983). Incubations were conducted at 37°C in PBS. H2O2
(50 to 500µM) was added to the medium, and H2O2 consumption was analyzed
on the basis of samples drawn during a 40-min incubation. The exact H2O2
concentration was determined spectrophotometrically using the molar extinction
coefficient of 44 M-1 cm-1 at 240 nm.
32
8. Measurement of ROS production (I)
Reactive oxygen species were assessed by chemiluminescence, with an
automated microcomputer-controlled luminometer. Untreated and cytokine-
treated cells after the 48-h incubation were used. The reaction mixture at 37°C in
1 ml contained  0.5-1x106 trypsinized and washed cells in PBS, 700 µl 10-4 M
luminol (5-amino-2,3-dihydro-1,4-phtalazinedione, LKB, Wallac), and in some
experiments 5-500 µM menadione. Chemiluminescence was measured for 30 min
in the presence and absence of  cytokines from both untreated and cytokine-
pretreated cells.
9. Measurement of cell injury
9.1. Trypan blue exclusion (V)
The cell suspension was incubated with trypan blue in PBS for 5 min at room
temperature. The cells were counted in a Bürker cell-counting chamber, and
trypan blue-negative cells were considered as viable cells.
9.2. Lactate dehydrogenase (LDH) release (I-III)
Lactate dehydrogenase release into the medium from cells cultured on 4- or 24-
well tissue culture plates was measured spectophotometrically, with pyruvic acid
(Sigma) as the substrate (Bergmeyer 1974). Total LDH was measured in cell
lysates obtained by treatment with 1% Triton X-100. The results are expressed as
percent of activity released into the medium.
9.3. Adenine nucleotide depletion (I-V)
For cytotoxicity experiments, in which cell injury was assessed by adenine
nucleotide depletion, cells cultured in 4- or 24-well tissue-culture plates were
preincubated with 0.1 mM 14C-adenine (specific activity 51 to 55 mCi/mmol (I-
IV) or 284-287 mCi/mmol (V); Amersham International) for 6 h (V), overnight
(I, III, IV), or for 48 h (II). After incubation, the labeled medium was removed,
and the cells were washed and exposed to H2O2, menadione, or FMLP in serum-
free RPMI-1640 medium as described previously. Experiments were terminated
by removing and freezing the medium at -20°C and extracting the cells with 0.42
N ice-cold perchloric acid. Purine nucleotides (ATP, ADP, and AMP) in
neutralized cell extracts, as well as total nucleotides and nucleotide catabolic
products (hypoxanthine, xanthine, and uric acid) in the medium were separated
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by thin-layer chromatography (Aalto and Raivio 1990). The separated purine
compounds were visualized on the chromatography sheets under ultraviolet light,
cut out, and counted in Optiphase ”High Safe”3 (LKB Scintillation Products,
FSA Laboratory Supplies, Loughborough, UK) by means of an LKB Wallac
Rackbeta 1209 liquid scintillation counter. Results are expressed as percent
distribution of radioactivity among nucleotides retained in the cell, nucleotides in
the medium, and their catabolic products.
10. Statistical methods
All experiments were performed at least in duplicate. Data analyses were
performed with the Stat View or SPSS for Windows software (SPSS Inc.,
Chicago, IL, USA). Two groups were compared by either the two-tailed
Student´s t-test (I, III, IV) or nonparametric Mann-Whitney U-test (II, V), and
multiple groups by analysis of variance (ANOVA) combined with Scheffé’s post
hoc test (I, III, IV) P values of < 0.05 were considered significant.
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RESULTS
1. Superoxide dismutases
1.1. Bronchial epithelial BEAS-2B cells
Bronchial epithelial cells (BEAS-2B) were used to study the regulation of
MnSOD and CuZnSOD by cytokines and hyperoxia in vitro. TNF-α (16, 24 and
48 h), a well-known inducer of MnSOD in a number of animal cell types (Wong
and Goeddel 1988, Harris et al. 1991), caused a significant increase in MnSOD
mRNA also in BEAS-2B cells (II; Figure 1). The mRNA levels increased until 24
h and then decreased, levels after 48 h still being higher than in untreated cells.
MnSOD protein was elevated by TNF-α and IFN-γ + TNF-α, but not by IFN-γ
alone (I; Figure 1). The specific activity of total SOD did not change significantly
after IFN-γ, TNF-α, or IFN-γ + TNF-α treatments (I; Table 1). The activity of
MnSOD was increased significantly by TNF-α (Table 1, I; Table1). In contrast to
the induction of MnSOD protein, MnSOD activity was further increased by the
combination of these cytokines (Table 1, I; Table 1).
Because preliminary hyperoxia experiments with BEAS-2B cells
indicated significant cell injury after 72 h exposure to hyperoxia (II), hyperoxia
exposures of 16 to 48 h were selected to investigate AOE regulation in BEAS-2B
bronchial epithelial cells. The mRNA levels and specific activities of MnSOD
and CuZnSOD remained unchanged after the hyperoxia exposure (Table 1, II;
Figures 1 and 2, Table 1). In conclusion, in human bronchial epithelial cells,
MnSOD was induced by TNF-α but not by high oxygen tension.
1.2. Mesothelial MET-5A cells
Mesothelial MET-5A cells were used to study the regulation of MnSOD by TNF-
α and asbestos fibers. TNF-α and amosite + TNF-α caused a significant
upregulation of MnSOD mRNA (III; Figure 1) and of specific activity (Table 1,
III; Figure 2) when compared to controls. The mRNA of MnSOD was not
significantly increased after amosite exposure, and the specific activity of
MnSOD showed no change. Total SOD activity remained unchanged in each case
(III; Figure 2). Thus in these experimental conditions, only TNF-α but not
asbestos fibers induced MnSOD activity.
CuZnSOD MnSOD Catalase GPx GR G6PDH
BEAS-2B unexposed 100 ± 36 100 ± 24 100 ± 18 100 ± 22 100 ± 12 100 ± 12
95% O2 48h 81 ± 29 119 ± 38 121 ± 21 67 ± 26 109 ± 12 -
IFN 10ng/ml 103 ± 7 124 ± 57 93 ± 11 149 ± 60 145 ± 11 135 ± 14
TNF 10ng/ml 92 ± 22 273 ± 12 92 ± 5 102 ± 31 114 ± 4 132 ± 7
IFN+TNF 86 ± 23 612 ± 297 75 ± 1 132 ± 22 113 ± 13 105 ± 31
MET-5A unexposed 100 ± 46 100 ± 26 - - - -
TNF 10ng/ml 76 ± 16 379 ± 203 - - - -
AMOS 2mg/cm2 87 ± 15 105 ± 32 - - - -
TNF+AMOS 92 ± 26 400 ± 103 - - - -
Table 1: Antioxidant enzyme activities of control BEAS-2B cells and cells exposed to hyperoxia for 48 h, IFN-γ (10ng/ml), TNF-α
(10ng/ml), or IFN-γ + TNF-α , and of control MET-5A cells and cells exposed to TNF-α (10ng/ml), AMOS (2µg/cm2), or TNF-α + AMOS.
Results are means ± SD from 3-6 separate experiments and expressed as % of the activity of control cells.
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1.3. Inflammatory cells
When MnSOD and CuZnSOD mRNA and protein levels and/or activities were
compared in freshly isolated neutrophils, monocytes, and alveolar macrophages,
and these levels were compared to those of differentiated monocytes expressing
features typical of macrophages, freshly isolated neutrophils had markedly higher
levels of MnSOD mRNA than mononuclear cells; neither the specific activity nor
protein, however, was higher (Table 2, V; Figure 1). The mRNA levels and
specific activities of CuZnSOD were similar in all cells investigated (Table 2, V).
SOD activities were not measured in alveolar macrophages, since the number of
BALs performed was limited, but the amount of immunoreactive MnSOD protein
was similar to that in freshly isolated monocytes (V; Figure 1). MnSOD mRNA,
immunoreactive protein, and specific activity were upregulated in macrophages
derived from monocytes upon in vitro culture (Table 2, V; Figure 1). Taken
together, the levels of MnSOD varied in different inflammatory cells, whereas
CuZnSOD appeared to be very similar in all cell types investigated.
1.4. Effect of cytokine-induced MnSOD on oxidant-related cytotoxicity
To investigate the protective role of MnSOD induction in cytokine-pretreated
cells, the cells were pretreated with TNF-α (BEAS-2B and MET-5A), with IFN-
γ, or with IFN-γ + TNF-α (BEAS-2B), with amosite asbestos fibers, or with a
combination of TNF-α and amosite (MET-5A). These cytokines themselves were
not toxic to the cells (I). Both untreated and cytokine-pretreated BEAS-2B cells
were very resistant to hyperoxia (I). However, pretreatment of these cells with
TNF-α or with TNF-α + INF-γ to cause MnSOD induction potentiated H2O2-
induced, menadione-induced (menadione, a compound which generates O2-
.
intracellularly), and hyperoxia-induced cell injury, which was assessed by LDH
release and adenine nucleotide depletion (I; Figures 2-5). This effect was most
significant with the combination of IFN-γ and TNF-α. Amosite and amosite +
TNF-α, but not TNF-α alone, caused significant injury in MET-5A cells, as
assessed by LDH release (III; Figure 3); and TNF-α caused significant adenine
nucleotide depletion (III; Figure 4). MET-5A cells, in which MnSOD was
induced by TNF-α and the amosite + TNF-α combination, were more sensitive to
menadione than were untreated cells (III; Figures 5 and 6).
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2. H2O2 scavenging mechanisms
2.1. Bronchial epithelial BEAS-2B cells
When the most important H2O2-scavenging antioxidant enzymes (catalase and
GPx) were investigated in cells treated with cytokines or exposed to high oxygen
tension, the activities of GPx, GR, and G6PDH underwent no change during
cytokine treatments (IFN-γ, TNF-α, or IFN-γ + TNF-α for 48 h); if anything, the
activity of catalase decreased after treatment of the BEAS-2B cells with IFN-γ +
TNF-α for 48 h (Table 1, I; Table 1). The mRNA levels and specific activities of
catalase, GPx, and GR remained unchanged after hyperoxia exposure when
followed for up to 48 h (Table 1, II; Figures 3 and 4, Table 1). However, although
total cellular glutathione content was significantly increased by hyperoxia (II;
Figure 8), this did not explain the increased oxidant resistance observed during
subsequent oxidant exposures in these cells, since depletion of glutathione by
buthionine sulfoximine failed to exacerbate the cell injury (II). Moreover, H2O2
consumption by normoxic and by hyperoxic cells was similar (II; Figure 7). Thus,
cytokines or hyperoxia in vitro induced none of the H2O2-scavenging enzymes.
2.2. Inflammatory cells
In comparative studies of different inflammatory cells, neutrophils were found to
contain higher levels of mRNA and of specific activity of catalase than did
monocytes, monocyte-derived macrophages, or alveolar macrophages (Table 2,
IV, V; Figure 2). Catalase was primarily localized in microperoxisomes, but was
also found in the cytoplasmic and nuclear matrices of alveolar macrophages (IV;
Figure 1, Table 1). The mRNA level and specific activity of GPx (Table 2, V;
Figure 3), as well as total glutathione (V; Figure 4), were lower in neutrophils
than in monocytes.
CuZnSOD MnSOD Catalase GPx GR
Inflammatory cells Monocytes 0h 10.7 ± 4.1 3.2 ± 2.6 88.0 ± 15.6 3.0 ± 0.9 45.4 ± 7.6
Monocytes 24h 8.0 ± 3.5 2.8 ± 1.7 85.6 ± 10.7 3.5 ± 1.2 36.5 ± 8.1
Monocytes 72h 7.5 ± 2.8 6.2 ± 2.6 68.6 ± 26.7 3.6 ± 0.9 38.8 ± 16.8
Neutrophils 7.1 ± 4.5 2.6 ± 1.8 368.3 ± 111.6 0.9 ± 0.9 27.0 ± 2.4
Alveolar
macrophages1
- - 76.8 ± 9.2 7.5 ± 1.8 31.0 ± 7.4
Table 2: Antioxidant enzyme activities (U/mg protein, GPx, and GR mU/mg protein) of inflammatory cells. Results are means ±
SD from 3-9 separate experiments. 1 Activities of alveolar macrophages are from a different study.
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2.3. Importance of different AOE pathways in oxidant-related cytotoxicity of
inflammatory cells
Cell viability studies showed that few, if any, neutrophils survived for 72 h,
whereas monocytes were able to maintain high-energy nucleotides for at least 120
h (V; Figure 5). On the other hand, monocytes and monocyte-derived
macrophages were more sensitive to exogenous H2O2 than were neutrophils,
whereas the respiratory burst induced by FMLP caused significant cell injury in
neutrophils, but not in monocytes or monocyte-derived macrophages (V; Figures
6 and 7). Pretreatment of cells with aminotriazole to cause catalase inactivation,
or with BCNU to inhibit GR, indicated that alveolar macrophages consumed
exogenous H2O2 mainly by the catalase-dependent pathway, whereas both the
GSH redox cycle and catalase were important in the maintenance of cellular high-
energy nucleotides (IV; Figures 3 and 5). In contrast to results of H2O2 -exposure,
the GSH cycle was more important than catalase in maintaining cellular integrity
of alveolar macrophages during the FMLP-induced respiratory burst (IV; Figures
2 and 4).
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DISCUSSION
1. Methodological aspects
Information about the molecular regulation of AOEs is contradictory and is
mostly based on animal models, and the situation in vivo is even more
complicated than in vitro, since inflammation can modulate the cellular responses
of various AOEs. Furthermore, since the regulation of AOEs is species- and age-
dependent, results from animal studies cannot be extrapolated to humans (Frank
1991). Healthy human tissue is difficult to obtain. In addition, ethical
requirements for studies on human cells and tissues limit the feasibility of these
kinds of studies. On the other hand, human bronchial epithelial cells change even
in primary culture, for instance cilia and surfactant disappear in vitro, and AOE
levels decrease within the first days in culture (Kinnula et al. 1992a).
Instead of primary cells, we used transformed human bronchial
epithelial (BEAS-2B) and mesothelial (MET-5A) cell lines, which are easy to
maintain and are therefore suitable for induction and cytotoxicity studies in vitro.
Transformed cells can be used in studies on enzyme regulation, since they
express all major AOEs (Kinnula et al. 1994), although not at levels comparable
to those of their non-transformed counterparts. In any case, when cell culture
methods are used, the extrapolation of results to in vivo conditions must be made
with caution. It is also noteworthy that cells are routinely cultured at 21% O2
concentration, which is normoxia for the airway epithelial cells and alveolar
macrophages, but not for mesothelial cells, monocytes, or neutrophils.
The isolation and purification procedures of monocytes and
macrophages are based on their ability to adhere to glass or plastic. The
advantage of separating monocytes and macrophages by adherence is that the
procedure is quick and easy and does not require complicated equipment.
However, because adherence is an activation event which can induce both gene
expression and protein secretion (Sporn et al. 1990), the induction of MnSOD
during monocyte differentiation in vitro may result from this adherence. In vitro-
matured macrophages were used in most experiments, since healthy human
alveolar macrophages, for ethical reasons, are difficult to obtain. The levels of
AOEs in freshly isolated cells are probably similar to their activities in vivo, since
previous studies have shown that the activities of these enzymes remain stable
during the first hours ex vivo (Kinnula et al. 1992a). Neutrophils may be
activated during isolation. Another problem is large interindividual variation even
when experimental conditions are exactly similar. However, the isolation and
study of these cells are important in understanding their role in the pathogenesis
of lung diseases.
The measurements of AOE activities have been well characterized.
In our protocol, the activities of CuZnSOD and MnSOD were distinguished by
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use of cyanide to inhibit CuZnSOD. This method has limited sensitivity, so in
some experiments the activity of MnSOD was undetectable. Catalase activity was
assayed by use of an oxygen electrode, which in the presence of excess H2O2
measures increased O2 production by catalase. Compared to this polarographic
method, a spectrophotometric method for assay of catalase was insensitive in our
laboratory.
Measurement of the depletion of radioactive-labeled adenine
nucleotides is a sensitive method for monitoring cell injury. Other indicators of
cell damage were also used, including trypan blue exclusion and LDH release.
Both of the latter methods measure lytic cell membrane injury. Adenine
nucleotide depletion is reversible and occurs much earlier than any cell
membrane injury. However, since nucleotide levels can be assessed only in viable
cells which have incorporated 14C-adenine, the values for adenine nucleotide
depletion overestimate the energy state and the viability of the whole cell
population. Adenine nucleotide depletion has been shown to correlate with cell
AOE levels, whereas no such relationship exists with lytic cell injury (Aalto et al.
1996). For example, the exposure to asbestos fibers or the combination with
TNF-α resulted in increased LDH release, which indicates irreversible cell
membrane damage. On the other hand, adenine nucleotide depletion was
observed only during simultaneous cytokine and amosite treatment, indicating
that these two methods measure different phenomena that do not necessarily
correlate with each other. The problem with the LDH-release assay is not only its
relative insensitivity, but also the inactivation of this enzyme under severe
oxidant stress, although this inactivation was not significant at the concentrations
of LDH and H2O2 used in this study (data not shown).
2. Superoxide dismutases
2.1. CuZnSOD
The role of SOD in pulmonary defense against oxygen toxicity has, since the
1970’s been extensively studied. Some of these studies have measured the
activity of total SOD instead of CuZnSOD in particular. Animals exposed to
sublethal hyperoxia show resistance to consequent exposure to 100% O2, and this
resistance correlates with increased SOD activity (Crapo and Tierney 1974).
Likewise, rats pre-exposed to hypoxia (10% O2) become tolerant to lethal
hyperoxia (Frank 1982), which is associated with increased pulmonary levels of
total SOD, catalase, and GPx activities. On the other hand, increased resistance to
hyperoxia has also been reported without induction of any AOEs (Baker et al.
1989), which agrees with our results with BEAS-2B cells, in which neither
increases in AOE-specific activities nor in glutathione concentration were
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necessary for the development of increased oxidant resistance. That CuZnSOD is
not usually induced by cytokines (Wong and Goeddel 1988, Visner et al. 1990,
Tsan et al. 1992) was shown also in the present study. Because antioxidant
enzymes other than CuZnSOD are induced by hyperoxia or cytokines, the
increased levels of CuZnSOD may not be responsible for the increased tolerance
to oxygen toxicity.
2.2. MnSOD
Some, but not all studies with adult rats have shown that the mRNA and/or the
specific activity of MnSOD is upregulated by hyperoxia in lung homogenates and
alveolar type II pneumocytes (Freeman et al. 1986, Clerch and Massaro 1993, Ho
et al. 1996). However, that immunoreactive protein, enzyme activity, and mRNA
level do not necessarily correlate with each other (Jornot and Junod 1992, Clerch
and Massaro 1993, Ho et al. 1996) indicates the complexity of the regulatory
mechanisms of this and other enzymes and may explain some of the discrepancies
found. In experimental animal models, MnSOD mRNA and/or protein are shown
to be induced by various cytokines (Tsan 1997), most importantly by TNF-α
(Wong and Goeddel 1988). After exposure of rats to hyperoxia the induction of
MnSOD in the lungs is maximal at days 3 to 5 (Ho et al. 1996), which is also the
time required for the recruitment of activated inflammatory cells into the lungs
(Barry and Crapo 1985). Because MnSOD, but not the other AOEs, is
upregulated by many cytokines (TNF-α, IL-1, IL-6, IFN-γ) (Wong and Goeddel
1988, Visner et al. 1990, Kinnula et al. 1995), the in vivo data on hyperoxia can
at least in part be explained by inflammation, nuclear factor-κB activation, and a
subsequent increase in MnSOD transcription (Das et al. 1995). In the present
study, with cultured cells, MnSOD mRNA was upregulated after 16 to 24 h of
TNF-α treatment. In contrast to studies conducted on human fibroblasts and
malignant cell lines (Harris et al. 1991), our results showed no elevation in
activity of MnSOD by IFN-γ, whereas the level of activity was significantly
elevated by TNF-α, and further elevated by the combination of IFN-γ + TNF-α.
No induction was observed in cells cultured in a hyperoxic atmosphere. These
results with BEAS-2B cells support the theory that in human airway epithelial
cells in vivo, inflammatory cytokines, but not oxygen, are responsible for the
regulation of MnSOD.
According to previous studies, asbestos fibers cause MnSOD mRNA
upregulation, increased immunocytochemical labeling, and increased specific
activity of this enzyme in isolated lung cells and in the intact lung upon inhalation
(Mossman et al. 1986, Holley et al. 1992). One recent study also showed a dose-
dependent increase in the steady-state mRNA levels of MnSOD in cells exposed
to crocidolite asbestos fibers (Janssen et al. 1994b). The specific activity of this
enzyme was not investigated in that study, but by Western blot analysis the
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enzyme protein was not significantly elevated. Two alternative mechanisms of
MnSOD upregulation by fibers have been considered: a direct fiber reaction or a
cytokine-mediated effect due to the proinflammatory properties of the fibers
(Kamp et al. 1992). The effect of asbestos fibers on MnSOD induction in vivo
and in vitro is not necessarily similar, because inflammation may modulate
cellular antioxidant response in vivo. In the present study, amosite had no effect
on MnSOD-specific activity in MET-5A cells, but because the fibers showed a
tendency for MnSOD mRNA upregulation, our results do not exclude the
possibility of MnSOD induction during prolonged asbestos exposure. On the
other hand, TNF-α and TNF-α + amosite caused a significant upregulation of
MnSOD mRNA and specific activity in MET-5A cells when compared to that in
unexposed cells. These data suggest that the MnSOD induction by inhaled fibers
observed in experimental asbestos models may be due to the proinflammatory
potential of the fibers rather than to a direct effect on the target cell.
Although inflammatory cytokines such as TNF-α are important in
the upregulation of MnSOD, the significance of MnSOD induction on oxidant
resistance is unclear. MnSOD induction by cytokines has been shown to confer
resistance to exogenous oxidants in some (Warner et al. 1991, Tsan 1997), but
not in all investigations (Marcho et al. 1991). Because hyperoxia results in ROS
generation in the mitochondria and endoplasmic reticulum (Freeman et al. 1982),
increased MnSOD activity can be expected to protect cells against hyperoxia. In
fact, TNF-α and endotoxin have been shown to prolong the survival of
experimental animals during hyperoxia exposure (Clerch and Massaro 1993, Tsan
1997), and transgenic and knock-out mice have shown that MnSOD expression
contributes to oxygen tolerance (Wispe et al. 1992, Tsan et al. 1998).  However,
resistance against hyperoxia is not necessarily associated with AOE induction
(Baker et al. 1989), a fact which agrees with our findings showing no MnSOD
upregulation in hyperoxia-exposed bronchial epithelial cells, despite increased
resistance to subsequent oxidant exposure. In addition, cytokine-induced MnSOD
offered no protection against endogenously or exogenously generated oxidants. In
contrast, increased sensitivity was observed both in BEAS-2B and in MET-5A
cells pretreated with cytokines. This finding is in line with the study of Marcho
and associates, which has shown enhanced sensitivity to oxidative stress in cells
containing high MnSOD activity (Marcho et al. 1991), but it contradicts the
finding that elevated MnSOD mRNA expression and activity increase resistance
to paraquat toxicity in human pulmonary adenocarcinoma cells (Warner et al.
1991). These contradictory data may be due to differences between transformed
and malignant human cell populations, to cell-specific effects of the cytokines, or
to the cytokine concentrations used. The protective effect of SOD may also be
related to SOD-level, since the ability of small doses of SOD to protect the
ischemically injured, reperfused rabbit heart is reversed at higher doses (Nelson
et al. 1994). A possible explanation may also be the overproduction of H2O2 and
subsequent enhanced lipid peroxidation due to an imbalance in cellular
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antioxidant mechanisms. In BEAS-2B and MET-5A cells, the effect of TNF-α
may in fact contribute to the induction of other mechanisms, for instance those
related to cell death (apoptosis). The balance of these reactions is complicated
and largely beyond the scope of the present study.
MnSOD may contribute to the protection of macrophages during
inflammation. Studies have investigated superoxide dismutases during in vitro
differentiation of monocytes and leukemia HL60 cells, but have not
systematically compared AOE activities in various inflammatory cell types or
investigated their significance. Our results are in agreement with data showing
induction of MnSOD during the differentiation of monocytes (Nakagawara et al.
1981, Asayama et al. 1985), but are in contrast with data on human leukemia HL-
60 cells, in which MnSOD mRNA remains unchanged and its activity decreases
during differentiation into granulocytes or macrophages (Speier and Newburger
1986, Kizaki et al. 1993). Our data on mRNA levels suggest, as the mechanism of
increased activity, transcriptional activation of MnSOD. However, previous and
present findings on the induction of MnSOD during monocyte differentiation in
vitro cannot be extrapolated to the situation in vivo, since these changes may
occur due to cell adherence (Sporn et al. 1990). Whether the induction related to
differentiation has relevance to the protection of macrophages in vivo remains
unclear.
In a number of inflammatory cell types, MnSOD is induced in
inflammatory cells by cytokines (Niwa et al. 1996, Tian et al. 1998). This
induction of MnSOD may thus play an important role in the resistance of
inflammatory cells during inflammation and oxidant stress. Based on one recent
study, MnSOD is induced in granulomatous diseases such as sarcoidosis,
especially in alveolar macrophages and granulomas (Lakari et al. 1998), but the
significance of this induction remains unclear. A previous study showed no
induction of MnSOD by TNF-α in human neutrophils (Kettritz et al. 1997),
whereas another study showed elevation of MnSOD immunoreactive protein in
human neutrophils treated with conditioned medium of human bronchial
epithelial cells (Cox et al. 1994). The higher levels of mRNA, but not the activity
of MnSOD in neutrophils, may be associated with activation of these cells during
cell isolation. Discrepancies between the mRNA levels and activities may be
related to differences in mRNA stability or translational efficiency of various
cells (Clerch and Massaro 1992, Dirami et al. 1999). Whether MnSOD is induced
in pathological conditions and contributes to the survival of these cells during
inflammation or infection remains to be investigated.
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3. H2O2 scavenging mechanisms
3.1. Catalase
In addition to MnSOD, catalase may also play an important role in protecting the
bronchial epithelium against oxidants. Although the regulation of SODs by
hyperoxia varies, the regulation of H2O2-scavenging enzymes is even more
contradictory. The changes in catalase have been marginal or insignificant (Rister
and Baehner 1976, Ho et al. 1996). The only in vivo study available on humans
showed no change in catalase levels after 16 h hyperoxia exposure (Erzurum et
al. 1993), which is consistent with the present study, in which catalase was not
induced by hyperoxia in BEAS-2B cells. In contrast to cell culture studies in
which only MnSOD is induced after cytokine exposure (Wong and Goeddel
1988), the pulmonary activity of catalase in rats treated with cytokines,
endotoxin, and/or with hyperoxia has also been found to be induced (Tsan et al.
1990a, Tsan et al. 1991, Clerch and Massaro 1993). In addition, the activity of
catalase has been shown to be elevated in macrophages of human smokers and in
hamster alveolar macrophages exposed to cigarette smoke (McCusker and Hoidal
1990). In the present study, treatment with the combination of TNF-α + IFN-γ
caused a significant decrease in catalase activity. The observations that human
bronchial epithelial cells have relatively low MnSOD and catalase levels and
activities with no induction by hyperoxia (Erzurum et al. 1993, Kinnula et al.
1994, Yoo et al. 1994) suggest that these characteristics may contribute to the
vulnerability of bronchial epithelial cells to toxic environmental effects.
Although cytokine treatment increases MnSOD activity, it may also
change the sensitivity of the cells to exogenous oxidants. Because superoxide is
rapidly converted to H2O2 nonenzymatically or by SODs in intact cells, increased
MnSOD activity may therefore lead to overproduction of H2O2 and to H2O2-
related injury. Our results are in agreement with findings on endothelial cells in
which TNF-α increases cell susceptibility to H2O2 and decreases glutathione
concentrations (Marcho et al. 1991). This can be explained by an imbalance
between various AOEs. The importance of antioxidant balance is further
supported by findings in which the hypersensitivity to oxidants of human
CuZnSOD-transfected cells is compensated for by co-transfection with the H2O2-
scavenging enzymes catalase or GPx (Amstad et al. 1991, Amstad et al. 1994).
Furthermore, the tolerance to hyperoxia of transgenic mice overexpressing
CuZnSOD is associated with a concomitant increase in GPx activity, and the
endotoxin-induced tolerance to oxygen with increased activities of catalase and
GPx (Clerch and Massaro 1993). In our experiments, both IFN-γ and TNF-α
enhanced cytotoxicity of H2O2, which may be a result of decreased catalase
activity. On the other hand, this explanation is questionable, because catalase was
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reduced only in cells pretreated with the combination of TNF-α and INF-γ. A
more likely possibility, therefore, is high MnSOD activity without a
corresponding or with only a minimal change in H2O2-scavenging systems,
leading to an imbalance in antioxidant capacity.
Catalase may play a prominent role in protection of inflammatory
cells, especially against severe oxidant stress. Previous studies have shown that
freshly isolated rat alveolar type II pneumocytes, which are highly resistant to
exogenous oxidants, contain high catalase activity (Kinnula et al. 1992a),
whereas more sensitive cells, bovine endothelial and rat mesothelial cells, have
low catalase protein and activity (Kinnula et al. 1992b, Kinnula et al. 1992c).
Human alveolar macrophages contain relatively high catalase activity (McDonald
et al. 1991). The present study revealed that neutrophils contain the highest
catalase activity of all phagocytes, and are more resistant to exogenous H2O2 than
are mononuclear cells. This high activity may play a profound role in proper
phagocytosis during the respiratory burst and the oxidant stress of activated
neutrophils. The importance of catalase is further supported by the differences in
the Km of catalase and GPx for H2O2, since the Km for catalase is markedly higher
than the Km for GPx (Jones et al. 1981), which suggests that catalase scavenges
H2O2 efficiently at high concentrations. In fact, the present and previous studies
have shown that alveolar macrophages consume exogenous H2O2 mainly by the
catalase-dependent pathway (McDonald et al. 1991). Although it is also possible
that mechanisms other than catalase may explain oxidant resistance of
neutrophils, the role of catalase is probably the most important.
Our results show that catalase is responsible for scavenging high
concentrations of H2O2 in alveolar macrophages. Although H2O2 is freely
diffusible, the localization of catalase raises the question whether catalase can
scavenge H2O2 of extracellular origin. Catalase is mainly localized in the
peroxisomes of alveolar macrophages (Davies et al. 1979), but is also found in
the cytosol of human neutrophils (Ballinger et al. 1994). We discovered that
catalase is localized mainly in the microperoxisomes, with some labeling also in
the cytoplasm and nuclei of alveolar macrophages. Whether the low
concentration of cytoplasmic catalase plays a substantial role in H2O2 scavenging
in human alveolar macrophages remains unclear. The catalase concentration in
the peroxisomes was about 200 times as high as that of the nucleus and the
cytoplasm. However, since the nucleus and the cytoplasm are much larger
compartments, they may contain, in total, about as much catalase as do the
peroxisomes. The fact that catalase-like activity scavenges exogenous H2O2
suggests also that there may be ATZ-inhibitable catalase-like activity in the cell
membrane. In our study, no catalase protein could be detected in the cell
membrane, but this negative finding does not mean that another form of ATZ-
inhibitable catalase-like activity is not present on the cell membrane of these
cells.
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3.2. Glutathione redox cycle
Because the glutathione redox cycle is complementary to catalase in scavenging
H2O2, it may therefore  be responsible for the protection of bronchial epithelium
against oxidant stress. In the present study, neither hyperoxia exposure nor
cytokine treatment had any effect on levels of GPx, GR or G6PDH. Thus,
indicating that other mechanisms seem to be involved in the protection of these
cells after prolonged oxygen exposure. Another potent antioxidative factor in
human bronchial epithelial cells has been suggested to be glutathione with the
enzymes regulating cellular glutathione levels (Cantin et al. 1987, Forman and
Skelton 1990). Rat alveolar macrophages are protected against hyperoxia by γ-
glutamyl transpeptidase, an enzyme that participates in glutathione transport
(Forman and Skelton 1990). That study showed that extracellular glutathione
protects cells against hyperoxia, and that this protection can be blocked by an
inhibitor of the transport enzyme, suggesting that the glutathione cycle is
important during oxidant exposure. Furthermore, previous studies have shown
increases in glutathione content, in cystine uptake, and in γ-glutamyl
transpeptidase activity in other cell types exposed to hyperoxia (Deneke and
Fanburg 1989, Knickelbein et al. 1996). In the present study, glutathione content
increased after hyperoxia exposure, which is in line with these findings.
However, the hypothesis that increased glutathione, and enzymes related to its
synthesis, explains the increased oxidant resistance of hyperoxia-exposed cells
was not supported by our findings in BEAS-2B cells, because glutathione
depletion by BSO did not potentate the cell injury in hyperoxic cells. H2O2
consumption by normoxic and hyperoxic cells was also identical, which further
suggests that mechanisms other than induction of AOEs or cellular glutathione
explain the resistance observed under these experimental conditions. However, it
has to be pointed out that glutathione may play a role in protection against
menadione, because this quinone can conjugate with glutathione.
In conclusion, the present data show that neither increases in AOE-
specific activities nor glutathione concentrations are necessary for the
development of increased oxidant resistance in BEAS-2B cells. The resistance to
oxidant stress and possibly also the resistance to hyperoxia may in part be
determined by inducible defense mechanisms other than AOEs and glutathione,
because the expression of several unidentified transcripts is known to be
modulated after nonlethal oxidant exposure (Wiese et al. 1995).
Glutathione metabolism may play an important role both in cell
viability and in protection against exogenous oxidants of inflammatory cells. This
theory is supported by data showing that phagocytes derived from patients with a
genetic deficiency in GSH synthetase or glutathione reductase are rapidly
damaged during phagocytosis (Roos et al. 1979, Spielberg et al. 1979), or
damaged when the reduction of oxidized glutathione is inhibited (Cohen et al.
1987). One previous study measuring the enzymes of the GSH cycle in
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neutrophils and monocytes showed very similar activities of GPx and GR in these
cells (Voetman and Roos 1980). In contrast, the present study showed that the
mRNA and specific activity of GPx, as well as glutathione levels, were lower in
neutrophils than in monocytes. The present study also showed that the
deterioration of cellular high-energy nucleotides was most prominent in BSO-
pretreated neutrophils, and that BCNU, which inhibits GR, was toxic only to
neutrophils. On the other hand, glutathione depletion had no effect on the
viability or energy state of oxidant-exposed inflammatory cells. Lower
concentrations of GPx and GSH may contribute to the short life-span of
neutrophils, since neutrophils lose their viability within 24 h ex vivo, and more
rapidly if glutathione is depleted (Curi et al. 1998), as shown also in the present
study.
The glutathione redox cycle may play a more important role in
protecting cells against physiologically relevant oxidant stress than does catalase.
GPx has a low Km for H2O2 in comparison to catalase, which favors the
predominant activity of GPx at low, physiologic H2O2 concentrations (Jones et al.
1981). Glutathione peroxidase is also distributed throughout the cytoplasm.
Furthermore, the glutathione redox cycle is active not only in the disposal of
H2O2 but also of the long-chain hydroperoxides and lipid peroxides which may
play an important role in membrane-related cell cytotoxicity (Andreoli et al.
1992). Exogenous oxidants cause ATP depletion within minutes of exposure,
whereas irreversible cell damage is apparent only after many hours (Spragg et al.
1985). Extracellular release of nucleotides reflects not only minimal cell injury
but also damage to the cell membrane. In the present study, human alveolar
macrophages were protected both by catalase and the glutathione redox cycle
against exogenous H2O2. Relatively low (100 µM) H2O2 concentrations were
used, but because H2O2 is freely diffusible, even this concentration may result in
higher intracellular H2O2 levels than those achieved during the transient
respiratory burst by FMLP. Nucleotide leakage into the extracellular space was
always highest in BCNU-pretreated cells. These results support the fact of the
primary importance of the glutathione cycle in the maintenance of the high-
energy nucleotide pool and of cell membrane integrity in vivo in human alveolar
macrophages.
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CONCLUSIONS
The present study explored the regulation and role of different AOEs during
oxidative stress in human lung cells. Based on the results presented in this thesis,
the main conclusions are:
1)  MnSOD is induced by TNF-α, but cytokine-induced MnSOD does not protect
bronchial epithelial cells against endogenously or exogenously generated
oxidants. In contrast, the cells with the highest MnSOD activity are those most
sensitive to subsequent oxidant damage. The balance between various
antioxidant enzymes, rather than the induction of one enzyme, is important for
protecting cells during oxidant exposure.
2)  AOEs are not directly upregulated by high oxygen tension. Increases in the
specific activities of AOEs and glutathione concentration are not necessary for
the development of increased oxidant resistance in human bronchial epithelial
cells.
3)  MnSOD is not induced by asbestos fibers alone in human mesothelial cells.
Asbestos fibers and TNF treatments render these cells more vulnerable to
oxidant-induced cell damage despite elevated MnSOD activity.
4)  Human alveolar macrophages scavenge exogenous H2O2 mainly by a catalase-
dependent pathway, whereas the glutathione redox cycle is responsible for the
maintenance of cellular integrity during the respiratory burst.
5)  Human inflammatory cells exhibit different antioxidant profiles. Monocytes
have higher levels of glutathione and of enzymes of the GSH cycle, whereas in
monocytes catalase activity is significantly lower than it is in neutrophils. The
high catalase activity of neutrophils may explain their high resistance against
exogenous H2O2, whereas low glutathione content and GSH-related enzymes
may account for the poor survival of human neutrophils.
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